Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$457,907
+$238,889 QoQ
Shares Held
1,803
+101.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#3,792
of 4,676 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Polymer Capital Management (US) LLC holds $2,503,906 across 7 Drug Manufacturers - General names. JNJ ranks #2 (18.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
3,646 | $468,511 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
1,803 | $457,907 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
6,585 | $379,427 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
2,655 | $335,432 | |
| 5 | BIIB |
Biogen Inc.
|
1,404 | $303,348 | |
| 6 | LLY |
ELI LILLY & Co
|
246 | $295,059 | |
| 7 | ABBV |
AbbVie Inc.
|
1,050 | $264,222 |
All Filings in JNJ
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $457,907 | 1,803 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $219,018 | 896 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $497,093 | 2,402 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $609,104 | 3,285 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||